Abstract:Graves' disease is known to be HLA-D associated; however, the primary loci involved remain unclear. We examined HLA genotypes of DRB1 and DQB1 plus DRB3 subtypes using PCR-based sequence-specific priming in two groups of North American (Gainesville, FL; and Toronto, Canada) Caucasian patients with Graves' disease. We stratified patients into those with either early age at onset (<20 yr; 13.1 +/- 4.8 yr; n = 30) and later age at onset of disease (38.8 +/- 9.7 yr; n = 62) and compared the results to 192 normal controls. As expected, we found that DRB1*03 was associated with Graves' disease, but at a higher odds ratios for early-onset than later-onset patients (3.7 vs. 2.2). The frequency of DRB1*08 was also increased in both groups of patients, but significantly so only in patients with early-onset Graves' (P = 0.001; chi(2) = 10.8). DRB3 was highly associated with Graves' in both groups of patients (P = 0.009; chi(2) = 6.83 and P = 0.0015; chi(2) = 10.1, respectively); however, the subtypes of DRB3 revealed differential susceptibilities. Whereas the frequencies of both DRB3*0101 and DRB3*0202 were increased over the entire cohort, that of DRB3*0301 was not. Significant P values were found for DRB3*0101 in patients with early-onset and for DRB3*0202 in patients with later onset of Graves' disease. When the haplotypes of DRB1*03-DRB3 of all subtypes were removed for analysis (all DRB1*03 positive also had DRB3*0101), the frequency of DRB3*0202 remained significantly higher in the patients with later onset of Graves' disease than in controls (P = 0.0043; chi(2) = 8.13), but DRB3 was no longer positively associated with the early-onset group. In addition, we found that DRB1*07 was negatively associated with both groups of patients (P = 0.024; chi(2) = 5.10 and P = 0.0085; chi(2) = 6.93). These data suggest that DRB3*0202 is more likely to be the primary susceptible locus than DRB1*03 for patients with later onset of Graves' disease.

SCGB3A2: A Validated Susceptibility Gene to Graves' Disease in Different Ethnic Populations

Functional SNPs in the SCGB3A2 Promoter Are Associated with Susceptibility to Graves' Disease

Recent Progress in Identification of Candidate Genes of Graves' Disease

The Association of SCGB3A2 Polymorphisms with the Risk of Graves’ Disease: a Meta-Analysis

Functional Single-Nucleotide Polymorphisms in the SCGB3A2 Promoter Are Associated with Susceptibility to Graves' Disease

Genetic Heterogeneity Of Susceptibility Gene In Different Ethnic Populations: Refining Association Study Of Ptpn22 For Graves' Disease In A Chinese Han Population

Identification of BACH2 as a susceptibility gene for Graves’ disease in the Chinese Han population based on a three-stage genome-wide association study

Clinical Associations of the Genetic Variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in Patients with Graves' Disease.

Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves’ disease in Chinese population

Association Between Rs3087243 and Rs231775 Polymorphism Within the Cytotoxic T-lymphocyte Antigen 4 Gene and Graves' Disease: a Case/control Study Combined with Meta-Analyses.

TSHR Gene Intron 1 Region Polymorphism and Its Relationship with Graves' Disease

Fine Mapping of Thyroglobulin Gene Identifies Two Independent Risk Loci for Graves’ Disease in Chinese Han Population

SAT-428 Sex-Specific Risk Gene of Graves’ Disease

Association Between 2q33 Gene Polymorphism and Graves' Disease

Association Between CTLA-4 Gene Polymorphisms and the Susceptibility to Graves' Disease

Genetic Study of Early-Onset Graves' Disease in the Chinese Han Population

Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroidism

HLA-DRB108, DRB103/DRB30101, and DRB30202 Are Susceptibility Genes for Graves' Disease in North American Caucasians, Whereas DRB107 Is Protective

Refined Association of TSH Receptor Susceptibility Locus to Graves' Disease in the Chinese Han Population.

Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence

Association Analysis of Single Nucleotide Polymorphisms in C1QTNF6, RAC2, and an Intergenic Region at 14q32.2 with Graves' Disease in Chinese Han Population